Browse Title Index

Issue Title
Vol 25, No 3 (2018) Oncology education for internal medicine residents: a call for action! Abstract   PDF   HTML
T. Younis, B. Colwell
Vol 21, No 1 (2014) Oncology education in Canadian undergraduate and postgraduate medical programs: a survey of educators and learners Abstract   PDF   HTML
V.C. Tam, S. Berry, T. Hsu, S. North, A. Neville, K. Chan, S. Verma
Vol 22, No 3 (2015) Ondansetron rapidly dissolving film for the prophylactic treatment of radiation-induced nausea and vomiting—a pilot study Abstract   PDF   HTML
E. Wong, N. Pulenzas, G. Bedard, C. DeAngelis, L. Zhang, M. Tsao, C. Danjoux, N. Thavarajah, B. Lechner, R. McDonald, P.M. Cheon, E. Chow
Vol 21, No 3 (2014) One compared with two cycles of mitomycin C in chemoradiotherapy for anal cancer: analysis of outcomes and toxicity Abstract   PDF   HTML
R. Yeung, Y. McConnell, G. Roxin, R. Banerjee, G.B. Roldán Urgoiti, A.R. MacLean, W.D. Buie, K.E. Mulder, M.M. Vickers, K.J. Joseph, C.M. Doll
Vol 17, No 2 (2010) One year of complete clinical response in a metastatic breast cancer patient treated with a combination of lapatinib and gemcitabine Abstract   PDF
J. M. Gasent Blesa, J. B. Laforga Canales, V. Alberola Candel
Vol 25, No 5 (2018) Only if you view it through a different lens Abstract   PDF   HTML
A. Abusanad
Vol 20, No 3 (2013) Opportunistic salpingectomy: the way forward—response to Steven Narod Abstract   PDF   HTML
D.M. Miller, J.N. McAlpine, C.B. Gilks, D.G. Huntsman
Vol 25, No 5 (2018) Opportunity is the greatest barrier to providing palliative care to advanced colorectal cancer patients: a survey of oncology clinicians Abstract   PDF   HTML   Supplemental Material
M. A. Earp, A. Sinnarajah, M. Kerba, P. A. Tang, J. Rodriquez-Arguello, S. King, S. M. Watanabe, J. E. Simon
Vol 14, No 5 (2007) Optimal Chemotherapy Treatment for Women with Recurrent Ovarian Cancer Details   PDF
Michael Fung-Kee-Fung, Thomas Oliver, Laurie Elit, Holger W Hirte, Peter Bryson
Vol 19, No 4 (2012) Optimal prophylactic and definitive therapy for bicalutamide-induced gynecomastia: results of a meta-analysis Abstract   PDF   HTML
M. A. Tunio, M. Al-Asiri, A. Al-Amro, Y. Bayoumi, M. Fareed
Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer Optimal systemic therapy for early breast cancer in women: a clinical practice guideline Abstract   PDF   HTML
A. Eisen, G.G. Fletcher, S. Gandhi, M. Mates, O.C. Freedman, S.F. Dent, M.E. Trudeau, members of the Early Breast Cancer Systemic Therapy Consensus Panel
Vol 16, No 3 (2009) Optimal use of taxanes in metastatic breast cancer Abstract   PDF
Karen M King, Sasha Lupichuk, Lubna Baig, Marc Webster, Sanraj Basi, Darlene Whyte, Serena Rix
Vol 21, No 5 (2014) Optimism about breakthroughs in the age of targeted therapy: the Canadian Lung Cancer Conference 2014; Vancouver, British Columbia; February 7, 2014 Abstract   PDF   HTML
B. Melosky, C. Ho
Vol 21, No 1 (2014) Optimizing outcomes with azacitidine: recommendations from Canadian centres of excellence Abstract   PDF   HTML
R.A. Wells, B. Leber, N.Y. Zhu, J.M. Storring
Vol 16, No 4 (2009) Optimizing the management of advanced non-small-cell lung cancer: a personal view Abstract   PDF
Mark D. Vincent
Vol 17, No 4 (2010) Optimizing the management of HER2-positive early breast cancer: the clinical reality Abstract   PDF
Su. Verma, S. Lavasani, J. Mackey, K. Pritchard, M. Clemons, S. Dent, J. Latreille, J. Lemieux, L. Provencher, Sh. Verma, S. Chia, B. Wang, D. Rayson
Vol 25, No 4 (2018) Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer—a survey of oncology nurses and physicians Abstract   PDF   Supplemental Material   HTML
N. LeVasseur, C. Stober, K. Daigle, A. Robinson, S. McDiarmid, S. Mazzarello, B. Hutton, A. Joy, D. Fergusson, J. Hilton, M. McInnes, M. Clemons
Vol 24, No 4 (2017) Oral Chinese herbal medicine as maintenance treatment after chemotherapy for advanced non-small-cell lung cancer: a systematic review and meta-analysis Abstract   PDF   HTML
Q. Wang, Q. Wang, S.F. Wang, L.J. Jiao, R.X. Zhang, Y. Zhong, J. Zhang, L. Xu
Vol 24, No 6 (2017) Orbital mass as first presentation of metastatic p16-positive oropharyngeal squamous cell carcinoma Abstract   PDF   HTML
J. Corbett, D. Wilke, J. Trites, N. Lamond
Vol 23 (2016): Original Cancer Costing Research Using Canadian Data Original Canadian cancer costing research for cancer control sustainability, quality, and value Abstract   PDF   HTML
H. Bryant
Vol 21, No 3 (2014) Ottawa Cardiac Oncology Program wins 2013 Cancer Quality Council of Ontario Innovation Award Abstract   PDF   HTML
J. Sulpher, C. Johnson, M. Turek, A. Law, E. Stadnick, S. Hopkins, N. Graham, S.F. Dent
Vol 22 (2015): Updated Guidelines, Consensus and Evidence-Based Reports in Breast Cancer Outcome of patients with pregnancy during or after breast cancer: a review of the recent literature Abstract   PDF   HTML
J. Raphael, M.E. Trudeau, K. Chan
Vol 26, No 4 (2019) Outcomes after intensity-modulated compared with 3-dimensional conformal radiotherapy with chemotherapy for squamous cell carcinoma of the anal canal Abstract   PDF   HTML
M. S. Agarwal, K. E. Hitchcock, C. G. Morris, T. J. George Jr, W. M. Mendenhall, R. A. Zlotecki
Vol 25, No 6 (2018) Outcomes by treatment modality in elderly patients with localized gastric and esophageal cancer Abstract   PDF   HTML
A. Natori, B. A. Chan, H. W. Sim, L. Ma, D. W. Yokom, E. Chen, G. Liu, G. Darling, C. Swallow, S. Brar, J. Brierley, J. Ringash, R. Wong, J. Kim, P. Rogalla, S. Hafezi-Bakhtiari, J. Conner, J. Knox, E. Elimova, R. W. Jang
Vol 19, No 4 (2012) Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer Abstract   PDF   HTML
T. Yung, M. E. Giuliani, L. W. Le, A. Sun, B.C.J. Cho, A. Bezjak, A. Brade, A. J. Hope
Vol 20, No 6 (2013) Outcomes of her2-positive early-stage breast cancer in the trastuzumab era: a population-based study of Canadian patients Abstract   PDF   HTML
U. Zurawska, D.A. Baribeau, S. Giilck, C. Victor, S. Gandhi, A. Florescu, S. Verma
Vol 19, No 3 (2012) Outcomes of surveillance for contralateral breast cancer in patients less than age 60 at the time of initial diagnosis Abstract   PDF   HTML
C. Weinstock, R. Bigenwald, T. Hochman, P. Sun, S.A. Narod, E. Warner
Vol 19, No 4 (2012) Outcomes of women with early-stage breast cancer receiving adjuvant trastuzumab Abstract   PDF   HTML
M. D. Seal, C. H. Speers, S. O'Reilly, K. A. Gelmon, S. L. Ellard, S. K. Chia
Vol 24, No 2 (2017) Ovarian cancer in Manitoba: trends in incidence and survival, 1992–2011 Abstract   PDF   HTML
P. Lambert, K. Galloway, A. Altman, M.W. Nachtigal, D. Turner
Vol 24, No 6 (2017) Ovarian function after chemotherapy in young breast cancer survivors Abstract   PDF   HTML
K. Morarji, O. McArdle, K. Hui, G. Gingras-Hill, S. Ahmed, E.M. Greenblatt, E. Warner, S. Sridhar, A.M.F. Ali, A. Azad, D.C. Hodgson
Vol 20, No 2 (2013) Overall survival should be the primary endpoint in clinical trials for advanced non-small cell lung cancer Abstract   PDF   HTML
P.K. Cheema, R.L. Burkes
Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist Overcoming endocrine resistance in hormone receptor–positive breast cancer Abstract   PDF   HTML
A. AlFakeeh, C. Brezden-Masley
Vol 25, No 3 (2018) Overcoming resistance in a BRAF V600E–mutant adenocarcinoma of the lung Abstract   PDF   HTML
T. Schmid, M. Buess
Vol 22, No 1 (2015) Overdiagnosis in breast cancer chemoprevention trials Abstract   PDF   HTML
V. Sopik, S.A. Narod
Vol 25, No 2 (2018) Overwhelming research and clinical evidence of exercise medicine efficacy in cancer management—translation into practice is the challenge before us Abstract   PDF   HTML
R.U. Newton
Vol 18, No 1 (2011) Oxaliplatin: a review in the era of molecularly targeted therapy Abstract   PDF   HTML
T. Alcindor, N. Beauger
Vol 19 (2012): Oncology in China Oxidative DNA damage of lymphocytes in peripheral blood and ascites in cancer patients Abstract   PDF   HTML
J. Wang, S. S. Xing, S. B. Guo, W. Jin, W. Zhang
Vol 20, No 4 (2013) Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy Abstract   PDF   HTML
H. Bhanabhai, R. Samant, C. E, L. Grenier, S. Lowry
Vol 23, No 5 (2016) Painless neutropenic enterocolitis in a patient undergoing chemotherapy Abstract   PDF   HTML
E.J. Chow, K.D. Bishop
Vol 24, No 3 (2017) Palliative care as a public health issue: understanding disparities in access to palliative care for the homeless population living in Toronto, based on a policy analysis Abstract   PDF   HTML
B. Henry, N. Dosani, L. Huynh, N. Amirault
Vol 26, No 1 (2019) Palliative care consultation and aggressive care at end of life in unresectable pancreatic cancer Abstract   PDF   HTML
C. Lees, S. Weerasinghe, N. Lamond, T. Younis, Ravi Ramjeesingh
Vol 26, No 1 (2019) Palliative care for cancer patients near end of life in acute-care hospitals across Canada: a look at the inpatient palliative care code Abstract   PDF   HTML
J. Tung, J. Chadder, D. Dudgeon, C. Louzado, J. Niu, R. Rahal, A. Sinnarajah
Vol 22, No 5 (2015) Palliative chemotherapy for patients 70 years of age and older with metastatic colorectal cancer: a single-centre experience Abstract   PDF   HTML
D. Bossé, M. Vickers, F. Lemay, A. Beaudoin
Vol 23, No 3 (2016) Palliative chemotherapy in advanced colorectal cancer patients 80 years of age and older Abstract   PDF   HTML
P. Lai, S. Sud, T. Zhang, T. Asmis, P. Wheatley-Price
Vol 21, No 2 (2014) Palliative sedation— still a complex clinical issue! Abstract   PDF   HTML
R.L. Fainsinger
Vol 18, No 3 (2011) Pan-Canadian initiatives in colorectal cancer screening: adopting knowledge translation tools to accelerate uptake and impact Abstract   PDF   HTML
H. E. Bryant, S. V. Fekete, D. H. Major
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 1 Abstract   PPT Presentation
S Sutcliffe, G. Deng, L. Wright, J. Maher, S. Sagar
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 2 Abstract   PPT Presentation
M. Philp, G. Payne, A. Cunningham, M. Vachon
2008: Presentations from the Integrating Wellness into Cancer Care Conference Panel Discussion 3 Abstract   PPT Presentation
B. Bell, Terry Sullivan, M. Vachon, P. Catton, A. Jadad, L. Morrison
Vol 20, No 6 (2013) Panitumumab monotherapy compared with cetuximab and irinotecan combination therapy in patients with previously treated KRAS wild-type metastatic colorectal cancer Abstract   PDF   HTML
H. Kennecke, L. Chen, C.D. Blanke, W.Y. Cheung, K. Schaff, C. Speers
Vol 26, No 5 (2019) Panitumumab-induced pulmonary toxicity Abstract   PDF   HTML
R. Arora, M. Kisiel, C. MacColl
Vol 24, No 5 (2017) Papillary thyroid carcinoma in a boy with familial tuberous sclerosis complex attributable to a TSC2 deletion—a case report Abstract   PDF   HTML
M. Flader, P. Kurzawa, J. Maldyk, J. Sygut, J. Harasymczuk, A. Kropinska, D. Handkiewicz-Junak, B. Jarzab, K. Kotulska, M. Niedziela
Vol 22, No 6 (2015) Para-aortic and pelvic extended-field radiotherapy for advanced-stage uterine cancer: dosimetric and toxicity comparison between the four-field box and intensity-modulated techniques Abstract   PDF   HTML
A. Rabinovich, L. Bernard, A.V. Ramanakumar, G. Stroian, W.H. Gotlieb, S. Lau, B. Bahoric
Vol 25, No 5 (2018) Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice—frequency and indications Abstract   PDF   HTML
S. A. Wong, B. I. Dalal, H. A. Leitch
Vol 16, No 6 (2009) Partial cancerous changes eventually developing into superficial spreading cancer over 18 months Abstract   PDF
Y. Song, Z. Wang, Q. Tang, H. Xu, C. Xing, Z. Miao, C. Yang
Vol 17, No 1 (2010) Pathology re-review as an essential component of breast cancer management Abstract   PDF
C.G. Kleer
Vol 18 (2011): The Optimization of Hormonal Therapy in Early Breast Cancer Patient adherence to aromatase inhibitor treatment in the adjuvant setting Abstract   PDF   HTML
S. Verma, Y. Madarnas, S. Sehdev, G. Martin, J. Bajcar
Vol 26, No 2 (2019) Patient decision aid for contralateral prophylactic mastectomy for use in the consultation: a feasibility study Abstract   PDF   HTML   Supplemental Material
J. E. Squires, D. Stacey, M. Coughlin, M. Greenough, A. Roberts, K. Dorrance, M. Clemons, J.M. Caudrelier, I. D. Graham, J. Zhang, M. Demery Varin, A. Arnaout
Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective Patient Decision-Making about Complementary and Alternative Medicine (CAM) in Cancer Management: The Context and Process Abstract   PDF
Lynda G Balneaves
Vol 26, No 1 (2019) Patient indications for Mohs micrographic surgery: a clinical practice guideline Abstract   PDF   HTML
C. Murray, D. Sivajohanathan, T. P. Hanna, S. Bradshaw, N. Solish, B. Moran, R. Hekkenberg, A. C. Wei, T. Petrella
Vol 21, No 2 (2014) Patient perceptions of a comprehensive cancer navigation service Abstract   PDF   HTML
W. Hryniuk, R. Simpson, A. McGowan, P. Carter
Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer Patient preference and the impact of decision-making aids on prostate cancer treatment choices and post-intervention regret Abstract   PDF   HTML
J. Aning, R.J. Wassersug, S.L. Goldenberg
Vol 21, No 2 (2014) Patient preferences for stopping tyrosine kinase inhibitors in chronic myeloid leukemia Abstract   PDF   HTML
D. Sanford, R. Kyle, A. Lazo–Langner, I. Chin–Yee, K. Howson–Jan, C. Hsia
Vol 22, No 4 (2015) Patient preferences for timing and access to radiation therapy Abstract   PDF   HTML
I.A. Olivotto, J. Soo, R.A. Olson, L. Rowe, J. French, B. Jensen, A. Pastuch, R. Halperin, P.T. Truong
Vol 22, No 3 (2015) Patient with inoperable pheochromocytoma Abstract   PDF   HTML
D. Brancíková, Z. Mechl, Z. Adam, E. Jandáková, Z. Pavlovský, V. Válek, Z. Andrašina
Vol 22, No 2 (2015) Patient-expressed perceptions of wait-time causes and wait-related satisfaction Abstract   PDF   HTML
M. Mathews, D. Ryan, D. Bulman
Vol 25, No 6 (2018) Patient-reported outcome measurement compared with professional judgment of cosmetic results after breast-conserving therapy Abstract   PDF   HTML
A.T.P.M. Brands-Appeldoorn, A.J.G. Maaskant-Braat, W.A.R Zwaans, J.P. Dieleman, K.E. Schenk, C.L. Broekhuysen, H. Weerdenburg, R. Daniels, V.C.G. Tjan-Heijnen, R.M.H. Roumen
Vol 26, No 4 (2019) Patient-reported outcomes in Alberta: rationale, scope, and design of a database initiative Abstract   PDF   HTML
C. A. Cuthbert, L. Watson, Y. Xu, D. J. Boyne, B. R. Hemmelgarn, W. Y. Cheung
Vol 25, No 6 (2018) Patients with advanced cancer: when, why, and how to refer to palliative care services Abstract   PDF   HTML
C. Courteau, G. Chaput, L. Musgrave, A. Khadoury
Vol 25, No 5 (2018) Patients with non-small-cell lung cancer harbouring a BRAF mutation: a multicentre study exploring clinical characteristics, management, and outcomes in a real-life setting: EXPLORE GFPC 02-14 Abstract   PDF   HTML
J. B. Auliac, S. Bayle, A. Vergnenegre, H. Le Caer, L. Falchero, R. Gervais, H. Doubre, F. Vinas, B. Marin, C. Chouaid
Vol 21, No 2 (2014) Patients’ perceptions of gene expression profiling in breast cancer treatment decisions Abstract   PDF   HTML
Y. Bombard, L. Rozmovits, M.E. Trudeau, N.B. Leighl, K. Deal, D.A. Marshall
Vol 24, No 6 (2017) Patterns of cancer centre follow-up care for survivors of breast, colorectal, gynecologic, and prostate cancer Abstract   PDF   HTML
R. Urquhart, L. Lethbridge, G.A. Porter
Vol 23, No 1 (2016) Patterns of care and treatment trends for Canadian men with localized low-risk prostate cancer: an analysis of provincial cancer registry data Abstract   PDF   HTML
K. Tran, R. Rahal, S. Fung, C. Louzado, G. Porter, J. Xu, H. Bryant
Vol 24, No 3 (2017) Patterns of failure in anaplastic and differentiated thyroid carcinoma treated with intensity-modulated radiotherapy Abstract   PDF   HTML
H. Vulpe, J.Y.Y. Kwan, A. McNiven, J.D. Brierley, R. Tsang, B. Chan, D.P. Goldstein, L.W. Le, A. Hope, M. Giuliani
Vol 20, No 5 (2013) Patterns of practice in the prescription of palliative radiotherapy for the treatment of bone metastases at the Rapid Response Radiotherapy Program between 2005 and 2012 Abstract   PDF   HTML
N. Thavarajah, L. Zhang, K. Wong, G. Bedard, E. Wong, M. Tsao, C. Danjoux, E. Barnes, A. Sahgal, K. Dennis, L. Holden, N. Lauzon, E. Chow
Vol 23, No 5 (2016) Patterns of practice with third-line anti-EGFR antibody for metastatic colorectal cancer Abstract   PDF   HTML
M.Y. Ho, D.J. Renouf, W.Y. Cheung, H.J. Lim, C.H. Speers, C. Zhou, H.F. Kennecke
Vol 18, No 6 (2011) Patterns of presentation, referral, and treatment of hepatocellular carcinoma in a pre-sorafenib era: experience of a Canadian provincial cancer agency Abstract   PDF   HTML
T. Sundaralingam, S. Gill
Vol 24, No 4 (2017) Patterns of spread and prognostic implications of lung cancer metastasis in an era of driver mutations Abstract   PDF   HTML
F. Hsu, A. De Caluwe, D. Anderson, A. Nichol, T. Toriumi, C. Ho
Vol 22, No 5 (2015) PEComa of the terminal ileum mesentery as a secondary tumour in an adult survivor of embryonal rhabdomyosarcoma Abstract   PDF   HTML
H. Hasan, A. F. Howard, A.H. Alassiri, T.L. Ng, G. McGregor, K. Goddard
Vol 26, No 4 (2019) Pembrolizumab-induced obstructive bronchiolitis in a patient with stage IV non-small-cell lung cancer Abstract   PDF   HTML
A. Blanchard, N. Bouchard
Vol 16, No 4 (2009) Perceptions of health care providers concerning patient and health care provider strategies to limit out-of-pocket costs for cancer care Abstract   PDF
Maria Mathews, Sharon K Buehler, Roy West
Vol 20, No 2 (2013) Perceptions of survivorship care among South Asian female breast cancer survivors Abstract   PDF   HTML
S. Singh-Carlson, S.K.A. Nguyen, F. Wong
Vol 25, No 4 (2018) Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer— a patient survey Abstract   PDF   Supplemental Material   HTML
N. LeVasseur, C. Stober, M. Ibrahim, S. Gertler, J. Hilton, A. Robinson, S. McDiarmid, D. Fergusson, S. Mazzarello, B. Hutton, A.A. Joy, M. McInnes, M. Clemons
Vol 14, No 1 (2007) Percutaneous cementoplasty of the lytic metastasis in left acetabulum Abstract   PDF
Kristin Harris
Vol 19, No 3 (2012) Pereira’s attack on legalizing euthanasia or assisted suicide: smoke and mirrors Abstract   PDF   HTML
J. Downie, K. Chambaere, J.L. Bernheim
Vol 19, No 6 (2012) Perianal Paget disease treated definitively with radiotherapy Abstract   PDF   HTML
J. Mann, A. Lavaf, A. Tejwani, P. Ross, H. Ashamalla
Vol 22, No 6 (2015) Pericardiocentesis versus pericardiotomy for malignant pericardial effusion: a retrospective comparison Abstract   PDF   HTML
C. Labbé, L. Tremblay, Y. Lacasse
Vol 21, No 2 (2014) Perioperative chemotherapy for gastroesophageal cancer in British Columbia: a multicentre experience Abstract   PDF   HTML
R.D. Peixoto, W.Y. Cheung, H.J. Lim
Vol 17, No 3 (2010) Peritoneal seeding and subsequent progression of mantle cell lymphoma after splenectomy for debulking Abstract   PDF
G. Bahat, B. Saka, M. N. Yenerel, E. Yilmaz, C. Tascioglu, O. Dogan
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Personalized choice of maintenance therapies in non-small-cell lung cancer Abstract   PDF   HTML
N. Blais, L. Corrales–Rodriguez
Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective Personalized medicine in metastatic non-small-cell lung cancer: promising targets and current clinical trials Abstract   PDF   HTML
A. Black, D. Morris
Vol 17, No 5 (2010) Personalized medicine: a personal view Abstract   PDF
S.A. Narod
Vol 23, No 6 (2016) Personalized oncogenomics in the management of gastrointestinal carcinomas— early experiences from a pilot study Abstract   PDF   HTML
B.S. Sheffield, B. Tessier-Cloutier, H. Li-Chang, Y. Shen, E. Pleasance, K. Kasaian, Y. Li, S.J.M. Jones, H.J. Lim, D.J. Renouf, D.G. Huntsman, S. Yip, J. Laskin, M. Marra, D.F. Schaeffer
Vol 26, No 2 (2019) Personalizing post-treatment cancer care: a cross-sectional survey of the needs and preferences of well survivors of breast cancer Abstract   PDF   HTML
J. Y. Y. Kwan, J. Croke, T. Panzarella, K. Ubhi, A. Fyles, A. Koch, R. Dinniwell, W. Levin, D. McCready, C. Chung, F. Liu, J. L. Bender
Vol 26, No 1 (2019) Perspectives on treatment advances for stage III locally advanced unresectable non-small-cell lung cancer Abstract   PDF   HTML
P. K. Cheema, J. Rothenstein, B. Melosky, A. Brade, V. Hirsh
Vol 25, No 2 (2018) Pharmacologic interventions for fatigue in cancer and transplantation: a meta-analysis Abstract   PDF   HTML
D. Tomlinson, P. D. Robinson, S. Oberoi, D. Cataudella, N. Culos-Reed, H. Davis, N. Duong, F. Gibson, M. Götte, P. Hinds, S.L. Nijhof, P. van der Torre, S. Cabral, L.L. Dupuis, L. Sung
Vol 25, No 1 (2018) Phase I study of concurrent and consolidation cisplatin and docetaxel chemotherapy with thoracic radiotherapy in non-small cell lung cancer Abstract   PDF   HTML
T.W. Zhang, G.B. Rodrigues, A.V. Louie, D. Palma, A.R. Dar, B. Dingle, W. Kocha, M. Sanatani, B. Yaremko, E. Yu, J. Younus, M.D. Vincent
Vol 19, No 1 (2012) Phase i study of the Plk1 inhibitor BI 2536 administered intravenously on three consecutive days in advanced solid tumours Abstract   PDF   HTML
A. Frost, K. Mross, S. Steinbild, S. Hedbom, C. Unger, R. Kaiser, D. Trommeshauser, G. Munzert
Vol 24, No 4 (2017) Phase I/II trial of dose-reduced capecitabine in elderly patients with advanced colorectal cancer Abstract   PDF   HTML
M.D. Vincent, D. Breader, M.C. Cripps, D.J. Jonker, P. Klimo, J.J. Biagi, W. Lam, A. O'Connell, F. Whiston, L. Stitt, S.A. Welch
Vol 14, No 4 (2007) Phase II Testing of Sunitinib: The NCIC CTG IND Program Trials IND.182 - 185 Abstract   PDF
Rena Julie Buckstein, Ralph M Meyer, Lesley Seymour, James Biagi, Helen MacKay, Scott Laurie, Elizabeth Eisenhauer
1001 - 1100 of 1678 Items << < 6 7 8 9 10 11 12 13 14 15 > >>